Back to mobile site

BMO Capital Starts Rocket Pharmaceuticals (RCKT) at Outperform

March 11, 2025 4:09 PM EDT Send to a Friend
(Updated - March 11, 2025 4:10 PM EDT)

BMO Capital analyst Kostas Biliouris initiates coverage on Rocket Pharmaceuticals (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login